Evidence map›Paper›PMID 33415015›Full record

ArticleAmerican journal of cancer research2020

Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic features.

Ruichuan Shi, Weixing Chen, Bowen Yang, Jinglei Qu, Yu Cheng, Zhitu Zhu, Yu Gao, Qian Wang, Yunpeng Liu, Zhi Li and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Clinical and prognostic implications of RAS mutations in metastatic colorectal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Ruichuan ShiDepartment of Medical Oncology, The First Hospital of China Medical University 110001, Liaoning, China.
Weixing ChenPaul C. Lauterbur Research Center for Biomedical Imaging, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences 518005, Guangdong, China.
Bowen YangDepartment of Medical Oncology, The First Hospital of China Medical University 110001, Liaoning, China.
Jinglei QuDepartment of Medical Oncology, The First Hospital of China Medical University 110001, Liaoning, China.
Yu ChengDepartment of Medical Oncology, The First Hospital of China Medical University 110001, Liaoning, China.
Zhitu ZhuCancer Center, The First Affiliated Hospital of Jinzhou Medical University 121001, Liaoning, China.
Yu GaoCancer Center, The First Affiliated Hospital of Jinzhou Medical University 121001, Liaoning, China.
Qian WangDepartment of Medical Oncology, Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University 110042, Liaoning, China.
Yunpeng LiuDepartment of Medical Oncology, The First Hospital of China Medical University 110001, Liaoning, China.
Zhi LiDepartment of Medical Oncology, The First Hospital of China Medical University 110001, Liaoning, China.
Xiujuan QuDepartment of Medical Oncology, The First Hospital of China Medical University 110001, Liaoning, China.
First Hospital of China Medical University · CNFirst Affiliated Hospital of Liaoning Medical University · CNLiaoning Cancer Hospital & Institute · CNShenzhen Institutes of Advanced Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a critical need for development of improved methods capable of accurately predicting the RAS (KRAS and NRAS) and BRAF gene mutation status in patients with advanced colorectal cancer (CRC). The purpose of this study was to investigate whether radiomics and/or semantic features could improve the detection accuracy of RAS/BRAF gene mutation status in patients with colorectal liver metastasis (CRLM). In this retrospective study, 159 patients who had been diagnosed with CRLM in two hospitals were enrolled. All patients received lung and abdominal contrast-enhanced CT (CECT) scans prior to radiation therapy and chemotherapy. Semantic features were independently assessed by two radiologists. Radiomics features were extracted from the portal venous phase (PVP) of the CT scan for each patient. Seven machine learning algorithms were used to establish three scores based on the semantic, radiomics and the combination of both features. Two semantic and 851 radiomics features were used to predict the mutation status of RAS and BRAF using an artificial neural network method (ANN). This approach performed best out of the seven tested algorithms. We constructed three scores which were based on radiomics, semantic features and the combined scores. The combined score could distinguish between wild-type and mutant patients with an AUC of 0.95 in the primary cohort and 0.79 in the validation cohort. This study proved that the application of radiomics together with semantic features can improve non-invasive assessment of the gene mutation status of RAS (KRAS and NRAS) and BRAF in CRLM.

Indexed as

artificial neural networkBRAFcolorectal cancerradiomicsRAS

Identifiers

PMID33415015
PMCPMC7783758
OpenAlexW3119127838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.